China Animal Vaccines Market Size & Outlook, 2024-2030
Related Markets
China animal vaccines market highlights
- The China animal vaccines market generated a revenue of USD 739.5 million in 2024 and is expected to reach USD 1,328.4 million by 2030.
- The China market is expected to grow at a CAGR of 10.5% from 2025 to 2030.
- In terms of segment, attenuated live vaccines was the largest revenue generating product in 2024.
- Recombinant Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
Animal vaccines market data book summary
| Market revenue in 2024 | USD 739.5 million |
| Market revenue in 2030 | USD 1,328.4 million |
| Growth rate | 10.5% (CAGR from 2025 to 2030) |
| Largest segment | Attenuated live vaccines |
| Fastest growing segment | Recombinant Vaccines |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines |
| Key market players worldwide | Zoetis, Ceva Santé Animale, Merck & Co Inc, Vetoquinol SA, Boehringer Ingelheim, Elanco Animal Health Inc, Virbac SA, Veterinary Pharmaceutical Solutions, Dechra Pharmaceuticals, IDEXX Laboratories Inc, Norbrook |
Other key industry trends
- In terms of revenue, China accounted for 5.5% of the global animal vaccines market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China animal vaccines market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,261.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Vaccines Market Scope
Animal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ceva Santé Animale | View profile | 5001-10000 | Libourne, Aquitaine, France, Europe | https://www.ceva.us |
| Norbrook | View profile | 1001-5000 | Newry, Newry and Mourne, United Kingdom, Europe | http://www.norbrook.com |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | http://www.dechra.com |
| Veterinary Pharmaceutical Solutions | View profile | 11-50 | Saint Peter, Minnesota, United States, North America | https://veterinarypharmaceuticalsolutions.com |
| Zoetis | View profile | 10001+ | Parsippany, New Jersey, United States, North America | https://www.zoetis.com |
| Vetoquinol SA | View profile | 2483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | http://www.vetoquinol.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| IDEXX Laboratories Inc | View profile | 11000 | One IDEXX Drive, Westbrook, ME, United States, 04092 | https://www.idexx.com |
| Elanco Animal Health Inc | View profile | 9800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | https://www.elanco.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
China animal vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal vaccines market will help companies and investors design strategic landscapes.
Attenuated live vaccines was the largest segment with a revenue share of 41.15% in 2024. Horizon Databook has segmented the China animal vaccines market based on attenuated live vaccines, inactivated vaccines, subunit vaccines, dna vaccines, recombinant vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing consumption of pork, meat, and beef and the threat from zoonotic diseases are major factors driving the growth of China animal vaccine market. Moreover, increasing initiatives being undertaken by the government and animal welfare associations to raise awareness about the numerous diseases in companion animals are expected to fuel the growth of the market.
In 2018, China undertook initiatives for educating the community about rabies prevention and established goals to complete dog vaccination registration program nationwide. Moreover, by 2020, it planned to raise the vaccinated percentage to at least 7% of the total dog population.
For instance, in 2018, Zoetis started construction of animal vaccine R&D and manufacturing facility in China to target widespread diseases in the country. The company anticipates that such vaccines will eventually become an essential health management tool in this industry. Foot-and-mouth disease is a highly infectious disease that threatens and hinders the development of the Chinese livestock sector.
Reasons to subscribe to China animal vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China animal vaccines market databook
-
Our clientele includes a mix of animal vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China animal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into China animal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China animal vaccines market size, by product, 2018-2030 (US$M)
China Animal Vaccines Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
